Oct 27, 2008 | 1
It’s hard to imagine an industry that isn’t affected by the global financial crisis, and science is no exception. The credit crunch will slow the development of new medicines, too, say economists and scientists meeting in London today and tomorrow.
The concern for novel treatments follows a boom time in the development of so-called “lifestyle drugs” to treat conditions such as impotence and baldness, which critics say has eclipsed innovation in treatments for serious diseases and those in developing countries where people cannot afford high-priced medicine. Investment in biotechs, companies that focus on developing new technologies from biology, last year hit a record-high $50 billion, but “the signs are that this has flattened,” says David Wield, director of the Economic and Social Research Council’s Innogen Center in Edinburgh.
Deadline: Dec 11 2013
Reward: $52,000 USD
Platform technologies – tools, techniques, and instruments that enable entirely novel approaches for scientific investigation across a b
Deadline: Jan 11 2014
Reward: $20,000 USD
Conventional washing machines cause excessive damage and wrinkling to clothes primarily during the water removal step. With the introduc
Give a 1 year subscription as low as $14.99X